In this respect, S100A11 expression was higher in bulk pancreatic cancer [9] tissues and intraductal papillary mucinous neoplasm than in non-neoplastic pancreatic tissue, and expression decreased with disease progression. Here, S100A11 is linked to pancreatic intraductal papillary-mucinous neoplasm.